Kinexum :: Drug Discovery and Lead Product Generation

Home : Services : Contracted : Drug Discovery

Lead Product Translation

Kinexum specializes in supporting discoverers and early stage biopharmaceutical companies with senior level scientific, clinical, and regulatory services to expedite drug development to achieve commercial-value milestones with high-level expertise. Using an established “virtual company model”, Kinexum’s integrated teams/systems enable the client to achieve key development milestones as the company transitions from the laboratory to human testing. Specializing in the diabetes, cardiovascular and oncology areas, Kinexum has provided support to nearly 50% of the current companies developing drugs in the diabetes area and for a growing list of oncology and cardiovascular products. Kinexum maximizes flexibility for the client in managing the bottom line without a build-up of expensive staffing infrastructure. Experienced teams have efficiently delivered commercially valued plans for more than 100 regulatory submissions and achieved significant milestones and business objectives resulting in increased value and funding and efficient decision making and risk management.

Kinexum’s range of services allows their clients to focus on their technology and skills while depending on Kinexum for missing expertise and functions that are not affordable as permanent staff or quickly obtainable. Using Kinexum’s services allows the client to advance the development of their product quicker and at lower fixed overhead expense, thus increasing value at much lower cost.